Friday, December 14, 2012
Excedrin was part of recall by drugmaker Novartis in January, migraine and headache sufferers have long awaited it return to the market.
Excedrin fans, rejoice! It's back. Have you purchased a bottle of Excedrin since it was re-stocked on shelves? Since January, migraine and headache sufferers been waiting and hoping for Excedrin to return after it was part of a massive recall in January. (Get instant news updates. Like Hazelwood Patch on Facebook and follow us on Twitter.) When Hazelwood Patch announced the recall, the article quickly became one of our most viewed articles. Many readers emailed not about participatingin the recall, but about when they could start purchasing the product again. It hit the shelves in October. Have your purchased a bottle? Or have you come to love the replacement you found following the recall? Tell us below in the comments section. Check out …
Wednesday, October 17, 2012
The product has been off the shelves since it was recalled in January.
Migraine sufferers, relief is in sight. Novartis, the manufacturer of Excedrin, announced Monday in an email to customers that Excedrin Migraine, which has been off the market since a January recall, is being shipped to stores this week. Novartis said that Excedrin Migraine should be back on store shelves in the next few weeks. Excedrin Migraine was one of several products recalled by Novartis in January after an internal investigation and complaints of "broken gelcaps, chipped tablets and inconsistent bottle packaging line clearance practices." Other recalled products included Bufferin, Gas-X, No-Doz and other Excedrin products. The company announced in August that production had resumed on Excedrin products.
Tuesday, January 10, 2012
Other Novartis products are included in the voluntary recall.
Drug manufacturer Novartis Consumer Health, Inc. (NCH) has issued a voluntary recall of four of its products: Excedrin, Bufferin, Gas-X and No-Doz. The National Public Radio health website reported that the products—made in a Lincoln, NE plant—may contain broken or chipped tablets, or "stray" tablets of a different medication. That factory has suspended production until Novartis sorts out its problems with quality control. The United States Food and Drug Administration (FDA) issued a press release on Jan. 8 with details on Novartis' voluntary recall, which included Excedrin and NoDoz products with expiration dates of Dec. 20, 2014 or earlier, and Bufferin and Gas-X products with expiration dates of Dec. 20, 2013 or earlier, in the United …